These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3670623)

  • 1. Magnetic resonance imaging of brain tumors: application of gadolinium-DTPA and comparison to computed tomography.
    Agnoli AL; Jungmann D; Lochner B
    Neurosurg Rev; 1987; 10(1):25-9. PubMed ID: 3670623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of hyperventilation for improving the visualization of glial tumors of the brain in magnetic resonance tomography using the contrast substance Gd-DTPA].
    Pronin IN; Kornienko VN; Petriaĭkin AV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (3):10-3. PubMed ID: 7483947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance tomography of brain tumors--comparison of the results using the multi-echo technic and gadolinium-DTPA].
    Heindel W; Steinbrich W; Friedmann G
    Rofo; 1986 Aug; 145(2):158-62. PubMed ID: 3018852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain.
    Stack JP; Antoun NM; Jenkins JP; Metcalfe R; Isherwood I
    Neuroradiology; 1988; 30(2):145-54. PubMed ID: 3386808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB; Riva A; Berger T; Stura G; Duca S
    Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors.
    Yamada S; Kubota R; Yamada K; Ono S; Hishinuma T; Matsuzawa T; Fujiwara S
    Tohoku J Exp Med; 1990 Feb; 160(2):145-8. PubMed ID: 2353348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.
    Schörner W; Kazner E; Laniado M; Sprung C; Felix R
    Neurosurg Rev; 1984; 7(4):303-12. PubMed ID: 6531081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Agnoli AL; Herrmann S
    Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd DTPA. Clinical efficacy.
    Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
    Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
    Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of contrast media in MRI at 0.02 T. A preliminary report.
    Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
    Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.
    Yoshida K; Furuse M; Kaneoke Y; Saso K; Inao S; Motegi Y; Ichihara K; Izawa A
    Magn Reson Imaging; 1989; 7(1):9-15. PubMed ID: 2918823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumors: MR imaging with gadolinium-DTPA.
    Felix R; Schörner W; Laniado M; Niendorf HP; Claussen C; Fiegler W; Speck U
    Radiology; 1985 Sep; 156(3):681-8. PubMed ID: 4040643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance imaging of tumours of the central nervous system: a clinical review.
    Graif M; Steiner RE
    Br J Radiol; 1986 Sep; 59(705):865-73. PubMed ID: 3756381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
    Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
    Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhancement of spontaneous animal CNS tumors with gadolinium DTPA: a correlation of MRI with x-ray CT.
    Goldstein EJ; Burnett KR; Wolf GL; Wortman J; Joseph P; Sen S
    Physiol Chem Phys Med NMR; 1985; 17(1):113-22. PubMed ID: 4034674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
    Powers TA; Partain CL; Kessler RM; Freeman MW; Robertson RH; Wyatt SH; Whelan HT
    Radiology; 1988 Dec; 169(3):723-6. PubMed ID: 3055036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of endothelial permeability in brain tumors by dynamic magnetic resonance tomography with magnevist contrast imaging on low-field MR-tomograph].
    Usov VIu; Velichko OB; Borodin OIu; Garganeev AB; Shikunov AA; Boklag ON
    Vestn Rentgenol Radiol; 2001; (3):22-9. PubMed ID: 12717930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.